Every year, over 500,000 people globally are diagnosed with leukemia
Complications arising from infections (sepsis) are the leading cause of death in people with leukemia, with some studies indicating this in up to 65% of leukemia cases. The mortality rate of sepsis in cancer patients is 30%.
Our mission is to fund cutting-edge medical research to reduce the sepsis mortality in patients with leukemia and other cancers.
The Foundation was set up in memory of our 18-year old son Jibraan who passed away in November 2024 as a result of sepsis associated with treatment of his leukemia.

Treatment of leukemia is a highly-complex medical challenge, integrating chemotherapy, radiation therapy, antibiotics and often culminates in a transplant from a closely-matched donor.
Unfortunately, the cocktail of therapies results in an obliteration of the patient’s blood cells and removes the ability to fight off bacteria, fungal and viral infections. During the time it takes for the bone marrow to remanufacture these cells, patients are highly susceptible to infection. The high number of antibiotics given during the course of treatment can result in some bacteria developing multi-antibiotic resistance. If the infection can not be treated, the life-threatening condition of Sepsis develops.
The purpose of the JCSR Foundation is to raise money to fund innovative and cutting-edge medical research into the management and treatment of infections and sepsis associated with chemotherapy treatment of Leukemia, which is currently a relatively underfunded part of medical research.
Our ultimate goal, in Jibraan’s memory, is to discover new treatment and management options to ensure that chemotherapy-associated sepsis is a thing of the past.
What is Leukemia?
There are many different types of Leukemia. Leukemia are cancers in the bone marrow, causing an abnormal increase in the number of white blood cells produced
What is Sepsis?
Sepsis occurs when the body’s immune response to an infection malfunctions. Sepsis is a life-threatening medical emergency. In patients undergoing chemotherapy for leukemia, sepsis rates have been reported as high as 63% in some studies.
Learn About Our Research Strategy
As we gear up towards awarding our first research grants, we have defined a comprehensive Research Strategy